Taiyi, Thunder-fire and herbal moxa

Short answer: medicated moxa sticks contain mugwort mixed with powdered herbs. According to the Journal of Chinese Medicine, physicians began adding medicinals to moxa rolls after pure-mugwort rolls appeared in the early Ming dynasty ^[1]. Well-known formulas include Taiyi and Thunder-fire (leihuo) moxa. Modern concerns include smoke toxicity, endangered ingredients and malpractice risk ^[1].

Types

What research reports on Thunder-fire moxibustion

• Lumbar disc herniation. A meta-analysis reported relief of discomfort, with a call for multicentre, large-sample RCTs because of quality limits ^[2].
• Low back pain. A meta-analysis reported that it “may have a better effect” than other treatments, but safety could not yet be assessed and the trials were of universally low quality ^[5].

Cautions

1. Know the ingredients. Added herbs vary. Customer reviews have raised questions about undeclared ingredients in products marketed as “pure moxa” ^[6]; those comments are demand evidence, not a verified formulation or pregnancy-safety finding. Request the actual ingredient declaration for the selected version.
2. Smoke. The Journal of Chinese Medicine discusses potential smoke toxicity for medicated sticks ^[1]. The amount and composition depend on the formulation and burning conditions; follow the selected product’s ventilation instructions ^[7].
3. Endangered species. Some historical formulas used ingredients from threatened species ^[1]. Ask suppliers for full botanical names.
4. Allergy. Added ingredients need to be considered in the assessment of the actual formulation; see Mugwort allergy.

For buyers, see Moxa Sourcing’s Taiyi, Thunder-fire and medicated moxa formats guide.

Why the formula name is not enough

“Taiyi,” “Thunder-fire” and “herbal moxa” describe traditions or product families, not one fixed ingredient list. The historical account explains how medicinals were added to rolls, while a modern patent and seller examples show different combinations of mugwort charcoal, other herbs and binders ^[1][3][4]. A patent is evidence that a formulation was described, not that every marketed stick uses it or that its clinical claims were proven.

That distinction also matters when reading research. The low-back reviews summarize Thunder-fire moxibustion interventions in their included trials; they do not identify the composition, emissions or performance of every product called Thunder-fire in a catalog ^[5][2]. The low-back-pain review explicitly could not assess safety and rated included trials low quality ^[5]. A research result therefore belongs to its studied protocol and population, not to the name printed on a pack.

A buyer’s ingredient and version record

For a reader, the practical answer to “is this medicated moxa?” is to inspect the actual ingredient declaration and product form. For a clinic or private-label buyer, ask for a versioned formula and a matching sample. Keep composition, product smoke behavior and clinical evidence as three separate questions. If an ingredient is disputed, identify the exact material and market before drawing a safety conclusion; a review comment alone cannot settle it.

What do the Thunder-fire reviews actually cover?

The low-back-pain review included 21 randomized trials and 2,198 patients, with a search through April 2021. It examined outcomes such as pain, disability, function and quality of life, and reported evidence levels ranging from very low to low ^[5]. Its authors described a possible advantage over the comparisons studied, while stating that safety could not yet be assessed. The review’s conclusion should retain both the favourable estimates and these limits.

The lumbar-disc-herniation review used a search through March 2022 and included 17 studies with 1,344 patients. Its eligibility covered Thunder-fire moxibustion alone or combined with other therapies ^[2]. It reported favourable estimates for its response, function and pain measures, but described the evidence as low or very low. These findings do not identify the composition of an arbitrary retail stick or isolate moxa from every accompanying treatment.

Why are those two totals not a new combined patient count?

The reviews concern related clinical subjects and can include overlapping literature. This page has not reconciled their underlying trial lists into a unique participant set. Adding 2,198 and 1,344 would therefore not establish the number of independent people who received a single defined intervention. The reviews also measure different outcomes and comparisons. Keep each source’s total with that source.

A “total effective rate” is a defined response measure in a review, not a general probability of cure. A pain-score result and a function-score result need their scales, timing and uncertainty. For a clinician or researcher, the relevant next step is the specific comparison and trial procedure; for a purchaser, it is whether the product being discussed corresponds to that procedure at all.

What was reported about harms?

The disc-herniation review states that only two included papers reported no adverse events, while the remainder had no relevant record ^[2]. That is a reporting distinction. It does not mean that all 17 studies actively monitored harms and observed none. The low-back-pain review’s inability to assess safety is another reason to avoid turning a product-family name into a safety assurance ^[5].

The useful question is whether the trial described how adverse events were sought, which participants contributed data and how follow-up was performed. If that information is absent, preserve the absence. It cannot be replaced with an ingredient list or an assertion that a formulation is traditional.

How should a named herbal formula be documented?

A formulation name, a material declaration and a finished-product specification describe different things. The historical account explains a tradition of adding medicinals to moxa ^[1]. The patent example describes a particular charcoal-and-herb preparation with binders ^[3]. A modern seller’s offered product needs its own declared ingredients and physical construction, even if it uses a familiar traditional name.

Ask for common and scientific names, the part of each plant where relevant, the processed form, and any binder or other component. Preserve the supplier’s wording as supplied; request clarification where a translated name is ambiguous. A list of species can help identify materials, but it does not by itself establish the proportions, processing or conformity of the finished article.

Which details belong to the finished stick?

Keep dimensions, mass or count as appropriate, core and wrapper construction, packing, compatible accessories and the accompanying instructions. If a quotation offers several formula variants, assign a clear reference to each and do not attach the test or instructions from one to all the others. An agreed sample should have a record that remains identifiable when artwork and later production are discussed.

For example, an illustrative documentation problem occurs when an enquiry says “Taiyi stick,” a sample arrives labelled “herbal moxa,” and a report names a different formula. This does not prove a defect or substitution. It identifies a correspondence question that must be resolved before those three records are treated as one product. The specification template can hold the clarified version.

What questions do smoke and ingredient concerns leave open?

A discussion of potential smoke toxicity in a historical or professional article is not an emissions report for every current mixture ^[1]. Equally, a low-smoke statement for one formulation does not transfer to a different herbal blend. Identify the actual tested material, method and conditions. If only a supplier description is available, attribute it as such.

An ingredient concern also needs the specific material and intended context. Knowing the complete declaration gives the responsible clinician or other professional a more useful starting point than a broad “natural” label. This page does not establish that every added herb has the same allergy profile, that every historical ingredient is present today, or that a named formula is suitable in pregnancy. See mugwort allergy and the pregnancy evidence page for their separate scopes.

How should a historical ingredient be handled in a modern enquiry?

Keep the historical description and modern declaration separate. If an old formula names an ingredient of conservation concern, do not assume its presence in the offered stick. Ask what the present product actually contains and which market it is intended for. Any material-specific trade or legal question then needs the exact species, product and route; an encyclopedia’s historical paragraph is not a current import authorization.

This distinction allows the cultural and formulation history to be presented without claiming that a modern product reproduces it exactly. It also prevents a supplier’s use of a classical name from silently becoming a claim that all ingredients, processing and clinical results are identical.

What should a buyer or reader do with this information?

For a research question, start with the relevant condition, comparison and outcome. For a product question, start with the actual formula declaration and sample. Bring those records together only where the correspondence is established. A useful brief can state the requested family or traditional name while listing what remains to be confirmed.

Before an order specification is agreed, retain the chosen version, ingredient clarification, physical format, instructions, packaging and any sample or report references. Compare changes explicitly: a new blend or binder is a reason to review which records still apply. For sourcing and private-label coordination, continue to the buyer guide and labelling discussion.

Related pages

• Back pain evidence
• Types of moxa products

Moxa Sourcing

Need a sourcing brief?

Moxa Sourcing helps brands and clinics compare product formats and samples, plan private-label packaging and coordinate export handoff. Start with your market, quantity and packaging goals.

What details help us start?

Share the format, market, quantity, packaging, destination and expected timing.

Buyer guideSend a buying brief